iRhythm
IRTC
Performance
About iRhythm
iRhythm provides end-to-end cardiac monitoring solutions centered on Zio ECG monitors and a comprehensive service ecosystem. The offering combines patient-friendly wearables with data collection, AI-assisted analysis, and clinician-facing reporting to support accurate arrhythmia diagnosis. The company emphasizes high patient compliance, high diagnostic yield, and seamless data integration for healthcare professionals across the United States and global markets. iRhythm positions itself as transforming cardiac monitoring with a patient-centric, data-driven approach.
Recent News
IRhythm Discloses Data Breach After Threat Actor Claims PHI Theft
Execs Map Path From AI Pilots to Enterprise Value, Targeting $1 B+ Gains
12 Most Profitable Blue Chip Stocks to Invest In Now
Labcorp Expands Epic Pact to Make Full Test Menu Available on Aura
IRhythm Q1 Revenue Jumps 25.7% to $199.4M as Wearable ECG Demand Holds Strong
Why Cardiac Monitoring Belongs at the Foundation of Your Service Line Strategy: A Conversation with Amanda Maples, RN, BSN, MHA
Recent Deals
No recent deals for this company.